Matsumoto T - Search Results

1

Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.

Matsumoto T, Fukunaga K, Kamikozuru K, Tozawa K, Yokoyama Y, Kusaka T, Onishi K, Miwa H, Nakamura S. Matsumoto T, et al. Transfus Med Hemother. 2008;35(1):18-23. doi: 10.1159/000111763. Epub 2007 Dec 21. Transfus Med Hemother. 2008. PMID: 21547106 Free PMC article.

2

Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.

Uchino M, Ikeuchi H, Matsuoka H, Bando T, Takahashi Y, Takesue Y, Matsumoto T, Tomita N. Uchino M, et al. Among authors: matsumoto t. Digestion. 2012;85(4):295-301. doi: 10.1159/000336719. Epub 2012 May 12. Digestion. 2012. PMID: 22584791

3

Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's disease.

Fukunaga K, Yokoyama Y, Kamikozuru K, Yoshida K, Kikuyama R, Nagase K, Nakamura S, Takei Y, Miwa H, Matsumoto T. Fukunaga K, et al. Among authors: matsumoto t. J Clin Apher. 2010;25(4):226-8. doi: 10.1002/jca.20242. J Clin Apher. 2010. PMID: 20544712

4

Hyperthermic stimulation of blood increases the immunological effects of granulocyte and monocyte adsorption in vitro: relevance to extracorporeal immunomodulation.

Tozawa K, Fukunaga K, Kamikozuru K, Ohnishi K, Hida N, Ohda Y, Kusaka T, Yoshida K, Jinno Y, Nagase K, Nakamura S, Miwa H, Matsumoto T. Tozawa K, et al. Among authors: matsumoto t. Transfus Apher Sci. 2008 Oct;39(2):129-35. doi: 10.1016/j.transci.2008.07.012. Transfus Apher Sci. 2008. PMID: 18762459

5

[Post-infectious IBS].

Kamikozuru K, Matsumoto T, Miwa H. Kamikozuru K, et al. Among authors: matsumoto t. Nihon Rinsho. 2006 Aug;64(8):1544-8. Nihon Rinsho. 2006. PMID: 16898630 Review. Japanese.

6

[Brain function in IBS patients].

Tozawa K, Miwa H, Ohda Y, Hida N, Matsumoto T. Tozawa K, et al. Among authors: matsumoto t. Nihon Rinsho. 2006 Aug;64(8):1536-9. Nihon Rinsho. 2006. PMID: 16898628 Review. Japanese.

7

Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study.

Fukuda Y, Matsui T, Suzuki Y, Kanke K, Matsumoto T, Takazoe M, Matsumoto T, Motoya S, Honma T, Sawada K, Yao T, Shimoyama T, Hibi T. Fukuda Y, et al. Among authors: matsumoto t. J Gastroenterol. 2004 Dec;39(12):1158-64. doi: 10.1007/s00535-004-1465-z. J Gastroenterol. 2004. PMID: 15622479 Clinical Trial.

8

Adsorptive Monocyte-granulocytapheresis (M-GCAP) for refractory Crohn's disease.

Kusaka T, Fukunaga K, Ohnishi K, Kosaka T, Tomita T, Yokoyama Y, Sawada K, Fukuda Y, Miwa H, Matsumoto T. Kusaka T, et al. Among authors: matsumoto t. J Clin Apher. 2004;19(4):168-73. doi: 10.1002/jca.20023. J Clin Apher. 2004. PMID: 15597346 Clinical Trial.

9

Heterogeneity of HPLC profiles of human class II MHC-bound peptides isolated from intestine with inflammatory bowel disease.

Oshitani N, Hato F, Jinno Y, Sawa Y, Hara J, Nakamura S, Matsumoto T, Arakawa T, Kitano A, Kitagawa S, Kuroki T. Oshitani N, et al. Among authors: matsumoto t. Dig Dis Sci. 2002 Sep;47(9):2088-94. doi: 10.1023/a:1019689332601. Dig Dis Sci. 2002. PMID: 12353860

10

Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.

Yokoyama Y, Fukunaga K, Fukuda Y, Tozawa K, Kamikozuru K, Ohnishi K, Kusaka T, Kosaka T, Hida N, Ohda Y, Miwa H, Matsumoto T. Yokoyama Y, et al. Among authors: matsumoto t. Dig Dis Sci. 2007 Oct;52(10):2725-31. doi: 10.1007/s10620-006-9560-z. Epub 2007 Apr 3. Dig Dis Sci. 2007. PMID: 17404876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results